Uncontrolled type 2 diabetes can lead to a multitude of health complications. Insulin therapy is recommended when patients are unable to reach their A1C goal with oral or noninsulin injectable diabetes medications. This study evaluated the clinical benefits of switching from multiple daily insulin injections to a wearable insulin delivery device (V-Go). A retrospective chart review was conducted on 44 patients who received prescriptions for the V-Go at two family medicine offices. Investigators found a significant reduction in A1C and daily insulin requirements with no impact on weight or BMI.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329021 | PMC |
| http://dx.doi.org/10.2337/cd20-0094 | DOI Listing |
Publication Analysis
Top Keywords
wearable insulin
8
insulin delivery
8
delivery device
8
type diabetes
8
daily insulin
8
insulin
5
evaluation clinical
4
clinical outcomes
4
outcomes v-go
4
v-go wearable
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!